231 related articles for article (PubMed ID: 22261062)
21. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC
Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975
[TBL] [Abstract][Full Text] [Related]
22. EphrinA1-EphA2 interaction-mediated apoptosis and FMS-like tyrosine kinase 3 receptor ligand-induced immunotherapy inhibit tumor growth in a breast cancer mouse model.
Tandon M; Vemula SV; Sharma A; Ahi YS; Mittal S; Bangari DS; Mittal SK
J Gene Med; 2012 Feb; 14(2):77-89. PubMed ID: 22228563
[TBL] [Abstract][Full Text] [Related]
23. Exosomal EPHA2 derived from highly metastatic breast cancer cells promotes angiogenesis by activating the AMPK signaling pathway through Ephrin A1-EPHA2 forward signaling.
Han B; Zhang H; Tian R; Liu H; Wang Z; Wang Z; Tian J; Cui Y; Ren S; Zuo X; Tian R; Niu R; Zhang F
Theranostics; 2022; 12(9):4127-4146. PubMed ID: 35673569
[No Abstract] [Full Text] [Related]
24. A conditional feedback loop regulates Ras activity through EphA2.
Macrae M; Neve RM; Rodriguez-Viciana P; Haqq C; Yeh J; Chen C; Gray JW; McCormick F
Cancer Cell; 2005 Aug; 8(2):111-8. PubMed ID: 16098464
[TBL] [Abstract][Full Text] [Related]
25. Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder.
Abraham S; Knapp DW; Cheng L; Snyder PW; Mittal SK; Bangari DS; Kinch M; Wu L; Dhariwal J; Mohammed SI
Clin Cancer Res; 2006 Jan; 12(2):353-60. PubMed ID: 16428472
[TBL] [Abstract][Full Text] [Related]
26. Drug-resistant cancer cell-derived exosomal EphA2 promotes breast cancer metastasis via the EphA2-Ephrin A1 reverse signaling.
Gao Z; Han X; Zhu Y; Zhang H; Tian R; Wang Z; Cui Y; Wang Z; Niu R; Zhang F
Cell Death Dis; 2021 Apr; 12(5):414. PubMed ID: 33879771
[TBL] [Abstract][Full Text] [Related]
27. Eph-A2 promotes permeability and inflammatory responses to bleomycin-induced lung injury.
Carpenter TC; Schroeder W; Stenmark KR; Schmidt EP
Am J Respir Cell Mol Biol; 2012 Jan; 46(1):40-7. PubMed ID: 21799118
[TBL] [Abstract][Full Text] [Related]
28. Protein kinase A can block EphA2 receptor-mediated cell repulsion by increasing EphA2 S897 phosphorylation.
Barquilla A; Lamberto I; Noberini R; Heynen-Genel S; Brill LM; Pasquale EB
Mol Biol Cell; 2016 Sep; 27(17):2757-70. PubMed ID: 27385333
[TBL] [Abstract][Full Text] [Related]
29. Spatial organization of EphA2 at the cell-cell interface modulates trans-endocytosis of ephrinA1.
Greene AC; Lord SJ; Tian A; Rhodes C; Kai H; Groves JT
Biophys J; 2014 May; 106(10):2196-205. PubMed ID: 24853748
[TBL] [Abstract][Full Text] [Related]
30. EphA2 promotes cell adhesion and spreading of monocyte and monocyte/macrophage cell lines on integrin ligand-coated surfaces.
Saeki N; Nishino S; Shimizu T; Ogawa K
Cell Adh Migr; 2015; 9(6):469-82. PubMed ID: 26565750
[TBL] [Abstract][Full Text] [Related]
31. Receptor-binding domain of ephrin-A1: production in bacterial expression system and activity.
Nekrasova OV; Sharonov GV; Tikhonov RV; Kolosov PM; Astapova MV; Yakimov SA; Tagvey AI; Korchagina AA; Bocharova OV; Wulfson AN; Feofanov AV; Kirpichnikov MP
Biochemistry (Mosc); 2012 Dec; 77(12):1387-94. PubMed ID: 23244735
[TBL] [Abstract][Full Text] [Related]
32. Engineering nanomolar peptide ligands that differentially modulate EphA2 receptor signaling.
Gomez-Soler M; Petersen Gehring M; Lechtenberg BC; Zapata-Mercado E; Hristova K; Pasquale EB
J Biol Chem; 2019 May; 294(22):8791-8805. PubMed ID: 31015204
[TBL] [Abstract][Full Text] [Related]
33. Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancer.
Efazat G; Novak M; Kaminskyy VO; De Petris L; Kanter L; Juntti T; Bergman P; Zhivotovsky B; Lewensohn R; Hååg P; Viktorsson K
Oncotarget; 2016 Sep; 7(37):60332-60347. PubMed ID: 27533087
[TBL] [Abstract][Full Text] [Related]
34. Roles of EphA1/A2 and ephrin-A1 in cancer.
Ieguchi K; Maru Y
Cancer Sci; 2019 Mar; 110(3):841-848. PubMed ID: 30657619
[TBL] [Abstract][Full Text] [Related]
35. Age-associated defects in EphA2 signaling impair the migration of human cardiac progenitor cells.
Goichberg P; Kannappan R; Cimini M; Bai Y; Sanada F; Sorrentino A; Signore S; Kajstura J; Rota M; Anversa P; Leri A
Circulation; 2013 Nov; 128(20):2211-23. PubMed ID: 24141256
[TBL] [Abstract][Full Text] [Related]
36. c-Cbl-dependent EphA2 protein degradation is induced by ligand binding.
Walker-Daniels J; Riese DJ; Kinch MS
Mol Cancer Res; 2002 Nov; 1(1):79-87. PubMed ID: 12496371
[TBL] [Abstract][Full Text] [Related]
37. Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.
Ishikawa M; Miyahara R; Sonobe M; Horiuchi M; Mennju T; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Huang CL; Date H
Lung Cancer; 2012 Jun; 76(3):431-8. PubMed ID: 22236865
[TBL] [Abstract][Full Text] [Related]
38. Biophysics. Enforcing order on signaling.
Paszek M; Weaver V
Science; 2010 Mar; 327(5971):1335-6. PubMed ID: 20223974
[No Abstract] [Full Text] [Related]
39. Effect of ephrin-A1/EphA2 on invasion of trophoblastic cells.
Yang Y; Min J
J Huazhong Univ Sci Technolog Med Sci; 2011 Dec; 31(6):824-827. PubMed ID: 22173506
[TBL] [Abstract][Full Text] [Related]
40. Theoretical Model of EphA2-Ephrin A1 Inhibition.
Jedwabny W; Lodola A; Dyguda-Kazimierowicz E
Molecules; 2018 Jul; 23(7):. PubMed ID: 29997324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
